Leaders in Learning: Publications of Faculty & Staff


Medicine 2001-2002


ADAMS, P.C.

Adams, P.C. 2002. Current therapy of hemochromatosis. Conn's Current Therapy. R.E. Rakel. Philadelphia: W.B. Saunders. 401-403.

Adams, P. C. 2002. Hemochromatosis: clinical implications. Medscape: [Online] Available at http://www.medscape.com/homeindex.

Adams, P.C. 2002. Hemochromatosis: diagnosis and management after the discovery of the gene. Molecular and Cellular Iron Transport. 1st ed. D. Templeton. New York: Marcel Dekker. 699-724.

Adams, P.C. 2001. Hemochromatosis: the irony of population screening. Scandinavian Journal of Gastroenterology 36 (10): 1009-1110.

Adams, P.C. 2002. Screening for hemochromatosis - should we be doing the last test first? British Columbia Medical Association Journal 44 (2): 83-85.

Adams, P.C., A.P. Walker, and R.T. Acton. 2001. A primer for predicting risk in HFE-related hemochromatosis. Genetic Testing 5 (4): 311-316.

Perrilo, R., Wright T., J. Rakela, G. Levy, E. Schiff, R. Gish, P. Martin, J. Dienstag, P.C. Adams, R. Dickson, G. Anscuetz, S. Bell, L. Condreay, and N. Brown. 2001. A multi-center United States - Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 33: 424-432.

Power, T.E., and P.C. Adams. 2001. Psychosocial impact of C282Y testing for hemochromatosis in screened and referred patients. Genetic Testing 5: 107-110.
 
 

ALMOND, D.G.

Almond, D. 2002. Coronary Stenting I: Intracoronay Stents - Form, Function and Future. Practical Interventional Cardiology. 2 ed. E.R.D. Grech. London, England: Martin Dunitz. 63-77.

Vlasic, W., D. Almond, and D. Massel. 2001. Reducing bedrest following arterial puncture for coronary interventional Procedures - Impact on Vascular Complications: The BAC Trial. Journal of Invasive Cardiology 13 (12): 788-792.
 
 

ARNOLD, J.M.O.

Arnold, J.M.O., W. Czarnecki, J.D. Parker, J. Howlett, A. Ignaszewski, S. Smith, A.R.J. Rajakumar, M.H. LeBlanc, P. Liu, D. Manyari, and I. Belenki. 2001. Community versus congestive heart failure (CHF) clinic drug utilization: The Canadian CHF clinics network 1999 - 2000. Journal of Cardiac Failure 17 (suppl C): 128C-129C.

Arnold, J.M.O., F. Gawadry-Sridhar, M. Calhoun, and S. Lawrence. 2001. Does intensive inpatient education of patients with heart failure (HF) during hospitalization result in fewer readmissions and visits to the emergency room (ER)? Canadian Journal of Cardiology 17 (Suppl C): 197C.

Liu, P., J.M.O. Arnold, M.I. Belenkie, J. Howlett, V. Huckell, A. Ignazewski, M.-H. LeBlanc, R. McKelvie, J. Niznick, J.D. Parker, V. Rao, H. Ross, D. Roy, S. Smith, B. Sussex, K. Teo, R. Tsuyuki, M. White, D. Beanlands, V. Bernstein, R. Davies, D. Issac, D. Johnstone, H. Lee, G. Moe, G. Newton, P. Pflugfelder, S. Roth, J. Rouleau, and S. Yusuf. 2001. The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure. Canadian Journal of Cardiology 17 (Suppl E): 5E-25E.

Mitchell, G.F., J.-C. Tardif, J.M.O. Arnold, G. Marchiori, T.X. O'Brien, M.A. Dunlap, and M.A. Pfeffer. 2001. Pulsatile hemodynamics in congestive heart failure. Hypertension (2001;38): 1433-1439.

Tsuyuki, R.T., R.S. McKelvie, J.M.O. Arnold, A. Avezum, A.C.P. Barretto, A.C.C. Carvalho, D.L. Isaac, A.D. Kitching, L.S. Piegas, K.K. Teo, and S. Yusuf. 2001. Acute precipitants of congestive heart failure exacerbations. Archives of Internal Medicine 161: 2337-2342.

White, M., J.L. Rouleau, C. Hall, J.M.O. Arnold, F. Harel, P. Sirois, S. Greaves, S. Scott, U. Ajani, R. Glyn, C. Hennekens, and M. Pfeffer. 2001. Neurohumoral activation and left ventricular remodeling following anterior myocardial infarction: The Healing and Early Afterload Reducing Therapy (HEART) neurhumoral ancillary study. 142: 1056-1064.
 
 

AUSTIN, T.W.

Kiaii, B., B.C. Moon, D. Massel, Y. Langlois, T.W. Austin, A. Willoughby, C. Guiraudon, C.R. Howard, and L.R. Guo. 2002. A prospective randomized trial of endoscopic versus conventional harvesting of the saphenous vein. Journal of Thoracic and Cardiovascular Surgery 123: 204-12.
 
 

BARR, R.M.

Allan, D.S., C.M. Thompson, R.M. Barr, W.F. Clark, and I.H. Chin-Yee. 2002. Ciprofloxacin-Associated Hemolytic-Uremic Syndrome. Annals of Pharmacotherapy 36 (6): 1000-1002.

Luk, C., K.M. Eckert, R.M. Barr, and I.H. Chin-Yee. 2002. A Prospective Audit of Fresh Frozen Plasma Utilization Using Canadian Medical Association Transfusion Guidelines. Canadian Medical Association Journal 166 (12): 1539-1540.
 
 

BEHME, M.T.

Behme, M.T., J.L. Mahon, and J. Dupre. 2002. Autoantibodies and HLA susceptibility markers in Canadian first degree relatives of patients with type 1 diabetes. Annals of the New York Academy of Sciences 958: 228-231.
 
 

BELL, D.A.

Beaton, M.D., and D.A. Bell. 2001. Scleroderma: A chronic disease with many facets. The Canadian Journal of Continuing Medical Education 13 (9): 51-62.

Huisman, A.M., K.P. White, A. Algra, M. Harth, R. Vieth, J.W.G. Jacobs, J.W.J. Bijlsma, and D.A. Bell. 2001. Vitamin D metabolites in female systemic lupus erythematosus and fibromyalgia patients. Journal of Rheumatology 28: 2535-2539.
 
 

BLAKE, P.G.

Blake, P.G. 2001. Integrated end-stage renal disease care: The role of peritoneal dialysis. Nephrology Dialysis Transplantation 16 (5): 61-66.

Blake, P.G., and K.H. Chu. 2001. Creatinine production and excretion in end-stage renal disease. American Journal of Kidney Diseases 38 (5): 1119-1122.

Blake, P.G., and J. Daugirdas. 2001. Physiology of peritoneal dialysis. Handbook of Dialysis. Third ed. J.T. Daugirdas, T.S. Ing, and P.G. Blake. Philadelphia: Lippincott Williams & Wilkins. 281-296.

Blake, P.G., and J.A. Diaz-Buxo. 2001. Adequacy of peritoneal dialysis and chronic peritoneal dialysis prescription. Handbook in Dialysis. Third ed. I.B. Daugirdas. Philadelphia: Lippincott Williams & Wilkins. 343-360.

Blake, P.G., and F.O. Finkelstein. 2001. Why is the proportion of patients doing peritoneal dialysis declincing in North America? Peritoneal Dialysis International 21 (2): 107-114.

Blake, P.G., and B. Stojimirovic. 2001. Peritoneal dialysis adequacy and risk of death. Current Opinion in Nephrology and Hypertension 10 (6): 749-754.

Clark, W.F., A.X. Garg, P.G. Blake, and G.A. Rock. 2001. Study awareness effect on utilization. Journal of the American Society of Nephrology 12: A1019.

Mendelssohn, D.C., P.G. Blake, J. Burkart, T. Holper, and D. Oreopoulos. 2001. Dialysis modality distribution in the United States. American Journal of Kidney Diseases 37 (6): 1330-1331.

Schaubel, D.E., P.G. Blake, and S.S.A. Fenton. 2001. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney International 60 (4): 1517-1524.

Schaubel, E.D., P.G. Blake, and S.S.A. Fenton. 2001. Trends in CAPD technique failure rates: Canada 1981-97. Peritoneal Dialysis International 21 (4): 365-371.

Sorkin, M.I., and P.G. Blake. 2001. Apparatus for peritoneal dialysis. Handbook in Dialysis. Third ed. J.T. Daugirdas, T.S. Ing, and P.G. Blake. Philadelphia: Lippincott Williams & Wilkins. 297-308.

Stojimirovic, B.B., P.G. Blake, and D.G. Oreopoulos. 2001. Assessing compliance with peritoneal dialysis. The International Journal of Artificial Organs 24 (9): 591-594.

Tonelli, M., P.G. Blake, and N. Muirhead. 2001. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. ASAIO Journal 47 (1): 82-85.
 
 

BORRIE, M.J.

Baker, A.D., C. Brymer, and M.J. Borrie. 2002. An Analysis of Ginkgo Biloba: Do You Get What You Pay For? Geriatrics Today 5 (1): 13-16.

Borrie, M.J. 2002. Post-Operative Acute Urinary Retention. Geriatrics and Aging 2002 (5): 2.

Borrie, M.J., M. Bawden, M. Speechley, and M. Kloseck. 2002. Interventions Led by Nurse Continence Advisers in the Management of Urinary Incontinence: A Randomized Controlled Trial. Canadian Medical Association Journal 166 (10): 1267-1273.

Borrie, M.J., C.D. Brymer, R.G. Crilly, D. Hindman, R. Pavlakovic, J. Esbaugh, and P. Stolee. 2001. Inappropriate Prescribing in Long Term Care Facilities: Prevalence and Associated Factors. Gerontolgoy 47 (Suppl 1): 557.

Borrie, M.J., K. Campbell, Z.A. Knezic, J. Bray, P. Hart, T. Labate, and P. Hesch. 2001. Urinary Retention on a Geriatric Rehabilitation Unit: Prevalence, Risk Factors and Validity of Bladder Scan Evaluation. Rehabilitation Nursing 26 (5): 187-191.

Borrie, M.J., P. Stolee, J. Feightner, J. Devereux, D. Harvey, and M. Vickers. 2001. Rural Community Development of Geriatric/Psychogeriatric Services in Southwestern Ontario. Gerontology 47 (Suppl 1): 515.

Borrie, M.J., P. Stolee, J.L. Wells, J. Seabrook, and F. Knoefel. 2001. Current Best Practices in Geriatric Rehabilitation in Canada. Geriatrics Today: Journal of the Canadian Geriatric Society 4 (3): 118.

Knoefel, F., B. Helliwell, M.J. Borrie, P. Stolee, and J. Wells. 2001. A Comparison of Functional Independence and Medical Complexity in Geriatric and Physical Medicine Rehabiliation In-patients. Geriatrics Today: Journal of the Canadian Geriatric Society 4 (3): 120-121.

Stolee, P., M.J. Borrie, J. Esbaugh, J. Wagg, M.G. Woodbury, R.J. Petrella, and I.A. Connidis. 2001. Maintenance of Functional and Quality of Life Outcomes in Geriatric Rehabilitation. Journal of the Canadian Geriatrics Society 4 (3): 122.

Stolee, P., J. Esbaugh, J. Wagg, M.J. Borrie, M. Vickers, and M.G. Woodbury. 2001. Measuring Client Satisfaction in Geriatric Rehabilitation. Journal of the Canadian Geriatrics Society 4 (3): 122-123.

Wells, J.L., M.J. Borrie, C.D. Brymer, R.G. Crilly, and J.S. Hurwitz. 2002. A Novel Clinical Pharmacy Experience for Third Year Medical Students. Canadian Journal of Clinical Pharmacology 9: 7-16.

Wells, J.L., M.J. Borrie, F. Knoefel, and P. Stolee. 2001. Geriatric Rehabilitation: Best Practices and Best Outcomes. Gerontology 47 (Suppl 1): 679.
 
 

BOUGHNER, D.R.

Duncan, A.C., D. Boughner, G. Campbell, and W.K. Wan. 2001. Preparation and characterization of a poly (2-hydroxyethyl methacrylate) biomedical hydrogel. European Polymer Journal 37: 1821-1826.

Talman, E.A., and D.R. Boughner. 2001. Effect of altered hydration on the internal shear properties of porcine aortic valve cusps. Annals of Thoracic Surgery 7: S375-8.

Weind, K.L., D.R. Boughner, L. Rigutto, and C.G. Ellis. 2001. Oxygen diffusion and consumption of aortic valve cusps. American Journal of Physiology. Heart and Circulatory Physiology 281: H2604-611.

Weind, K.L., Ellis C.G., and D.R. Boughner. 2002. Aortic valve cusp vessel density: relationship with tissue thickness. Journal of Thoracic and Cardiovascular Surgery 123: 333-340.
 
 

BRYMER, C.D.

Baker, A.D., C. Brymer, and M.J. Borrie. 2002. An Analysis of Ginkgo Biloba: Do You Get What You Pay For? Geriatrics Today 5 (1): 13-16.

Borrie, M.J., C.D. Brymer, R.G. Crilly, D. Hindman, R. Pavlakovic, J. Esbaugh, and P. Stolee. 2001. Inappropriate Prescribing in Long Term Care Facilities: Prevalence and Associated Factors. Gerontolgoy 47 (Suppl 1): 557.

Brymer, C., C. McKenzie, and J. Hurwitz. 2002. Use of the Levodopa test in the assessment of Parkinsonism on a geriatric inpatient unit. Geriatrics Today 5 (1): 22-28.

Diachun, L.D., J.L. Wells, J. Esbaugh, and C.D. Brymer. 2001. The Efficacy of Experential Learning of Geriatric Curriculum in First Year Medical Students at UWO. Geriatrics Today 4 (3): 117-118.

Naglie, G., S. Radomski, C. Brymer, K. Matthiasen, K. Rourke, and G.A. Tomlinson. 2002. A randomized, double-blind, placebo-controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. Journal of Urology 167: 586-590.

Wells, J.L., M.J. Borrie, C.D. Brymer, R.G. Crilly, and J.S. Hurwitz. 2002. A Novel Clinical Pharmacy Experience for Third Year Medical Students. Canadian Journal of Clinical Pharmacology 9: 7-16.
 
 

CHIN-YEE, I.H.

Allan, D.S., M. Keeney, K. Howson-Jan, J. Popma, K. Weir, M. Bhatia, D.R. Sutherland, and I.H. Chin-Yee. 2002. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 29 (12): 967-972.

Allan, D.S., C.M. Thompson, R.M. Barr, W.F. Clark, and I.H. Chin-Yee. 2002. Ciprofloxacin-Associated Hemolytic-Uremic Syndrome. Annals of Pharmacotherapy 36 (6): 1000-1002.

Brown, W., S. Kaplan, M. Keeney, K. Johnson, N. Wolfe, and I.H. Chin-Yee. 2001. Workflow Improvement with Random Access and Enhanced Flagging on the New Coulter LH 750 Hematology Analyzer. Laboratory Hematology 7: 229-235.

Chin-Yee, I.H., M. Keeney, K. Johnson, W. Brown, N. Wolfe, and S. Kaplan. 2001. White Blood Cell Flagging Rates of the Coulter LH750 Analyzer Compared with the Coulter G. S. Hematology Analyzer. Laboratory Hematology 7: 211-216.

d'Almeida, M.S., D. Gray, C. Martin, C.G. Ellis, and I.H. Chin-Yee. 2001. Effect of prophylactic transfusion of stored RBCs on oxygen reserve in response to acute isovolemic hemorrhage in a rodent model. Transfusion 41 (7): 950-956.

Eichelbronner, O., M. D'Almeida, A. Sielenkamper, W.J. Sibbald, and I.H. Chin-Yee. 2002. Increasing P50 does not improve DO2crit or systemic VO2 in severe anemia. American Journal of Physiology. Heart and Circulatory Physiology 283 (July): H92-101.

Keeney, M., W. Brown, and I.H. Chin-Yee. 2001. Platelet counts and flagging rates from LH750 Hematology Analyzer Compared with the ICSH/ISLH Platelet Reference Method and the Gen S. Hematology Analyzer. Laboratory Hematology 7: 204-210.

Luk, C., K.M. Eckert, R.M. Barr, and I.H. Chin-Yee. 2002. A Prospective Audit of Fresh Frozen Plasma Utilization Using Canadian Medical Association Transfusion Guidelines. Canadian Medical Association Journal 166 (12): 1539-1540.

Murdoch, B., L. Gallacher, C. Awaraji, D.A. Hess, M. Keeney, K. Jay, K. Chadwick, S.R. Foley, K. Howson-Jan, I.H. Chin-Yee, D.M. Wu, E. Srour, F. Fellows, and M. Bhatia. 2001. Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. FASEB Journal 9 (July 15): 1628-1630.

Tinmouth, A., and I.H. Chin-Yee. 2001. The Clinical Consequences of the Red Cell Storage Lesion. Transfusion Medicine Reviews 15 (2): 91-107.

Wei Xu, G.W., C.L. Nutt, M.D. Zlatescu, M. Keeney, I.H. Chin-Yee, and J.G. Cairncross. 2001. Inactivation of p53 Sensitizes U87MG Glioma Cells to 1,3-bis(2-Chloroethyl)-1-nitrosourea1. Cancer Research 61: 4155-4159.
 
 

CHOW, L.H.

Li, S., Y.-S. Fan, L.H. Chow, C. Van Den Diepstraten, E. van der Veer, S.M. Sims, and J.G. Pickering. 2001. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circulation Research 89: 517-525.
 
 

CLARK, W.F.

Allan, D.S., M.J. Kovacs, and W.F. Clark. 2001. Frequently Relapsing Thrombotic Thrombocytopenic Purpura Treated with Cytotoxic Immunosuppressive Therapy. Haematologica 8 (August): 844-850.

Allan, D.S., C.M. Thompson, R.M. Barr, W.F. Clark, and I.H. Chin-Yee. 2002. Ciprofloxacin-Associated Hemolytic-Uremic Syndrome. Annals of Pharmacotherapy 36 (6): 1000-1002.

Clark, W.F., A.X. Garg, P.G. Blake, and G.A. Rock. 2001. Study awareness effect on utilization. Journal of the American Society of Nephrology 12: A1019.

Garg, A.X., W. Clark, R.B. Haynes, and A.A. House. 2002. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney International 61 (4): 1486-1494.
 
 

CRILLY, R.G.

Borrie, M.J., C.D. Brymer, R.G. Crilly, D. Hindman, R. Pavlakovic, J. Esbaugh, and P. Stolee. 2001. Inappropriate Prescribing in Long Term Care Facilities: Prevalence and Associated Factors. Gerontolgoy 47 (Suppl 1): 557.

Chesworth, B.M., M. Speechley, K. Hartford, and R. Crilly. 2001. Home Care Use After Hip Fracture in a Health Planning Region. Canadian Journal of Public Health 92 (5): 380-384.

Chesworth, B.M., M. Speechley, K. Hartford, and R. Crilly. 2002. Relationship Between Acute Care Hospital-based Factors and Discharge Destination for Rehabilitation Following a Hip Fracture. Canadian Journal of Aging 21 (2): 187-194.

Chesworth, B.M., M. Speechley, K. Hartford, and R.G. Crilly. 2001. Home Care After Hip Fracture in a Health Planning Region. Canadian Journal of Public Health 92 (5): 380-384.

Kloseck, M., R.G. Crilly, and L. Hutchinson-Troyer. 2001. Measuring Outcomes in Rehabilitation. Therapeutic Recreation Journal 35 (1): 31-42.

Wells, J.L., M.J. Borrie, C.D. Brymer, R.G. Crilly, and J.S. Hurwitz. 2002. A Novel Clinical Pharmacy Experience for Third Year Medical Students. Canadian Journal of Clinical Pharmacology 9: 7-16.
 
 

CRUICKSHANK, M.K.

Massel, D., and M.K. Cruickshank. 2002. The number remaining at risk. An adjunct to the number needed to treat. Canadian Journal of Cardiology 18: 254-258.
 
 

DIACHUN, L.L.

Diachun, L.D., J.L. Wells, J. Esbaugh, and C.D. Brymer. 2001. The Efficacy of Experential Learning of Geriatric Curriculum in First Year Medical Students at UWO. Geriatrics Today 4 (3): 117-118.

Parker, H., and L. Diachun. 2001. Risky Business: Examining our response to the elderly living at risk. Geriatrics and Aging 4 (9): 28-29.
 
 

DIAS, B.

Butany, J., B. Dias, P. Iyengar, R. Leask, and S. Brister. 2002. Acute Mitral Regurgitation Due to a Torn Porcine Bioprosthetic Cusp. Circulation 10: 58-60.

Dias, B., A. Barolet, A. Ralph-Edwards, J. Graba, B. Mohsen, and J. Butany. 2002. Left Atrial Mass. Canadian Journal of Cardiology 18: 82-84.
 
 

DRESSER, G.

Dresser, G., D. Baileym, B. Leakem, U. Schwartz, P. Dawson, D. Freeman, and R. Kim. 2002. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral bioavailability of fexofenadine. Clinical Pharmacology and Therapeutics 71 (1): 11-20.
 
 

DUPRE, J.

Behme, M.T., J.L. Mahon, and J. Dupre. 2002. Autoantibodies and HLA susceptibility markers in Canadian first degree relatives of patients with type 1 diabetes. Annals of the New York Academy of Sciences 958: 228-231.
 
 

FEAGAN, B.G.

Feagan, B.G., C.J. Wong, W.C. Johnston, R. Arellano, N. Colterjohn, K. Karkouti, and K. Turner. 2002. Transfusion Practices for Elective Orthopedic Surgery. Canadian Medical Association Journal 166 (3): 310-314.

McDonald, J.W.D., J. Mahon, K. Zarnke, B. Feagan, L. Simms, and W. Tucker. 2002. A Randomized Survey of the Preference of Gastroenterolgists for a Cochrane Review versus a Traditional Narrative Review. Canadian Journal of Gastroenterology 16 (1): 17-21.

Sandborn, W.J., B.G. Feagan, S.B. Hanauer, H. Lochs, R. Lofberg, R. Modigliani, D.H. Present, P. Rutgeerts, J. Scholmerich, E.F. Stange, and L. Sutherland. 2002. A Review of Activity Indices and Efficacy Endpoints for Clinical Trials of Medical Therapy in Adults with Crohn's Disease. Gastroenterology 122 (2): 512-530.
 
 

FELDMAN, R.D.

Feldman, R.D. 2001. Adrenergic Receptor Polymorphisms and Cardiac Function (and Dysfunction): A Failure to Communicate? Circulation 103: 1042-1043.

Feldman, R.D. 2001. A helping hand in the management of blood pressure. Lancet 357: 1372-1373.

Feldman, R.D., and N.D. Schmidt. 2001. Quinapril treatment enhances vascular sensitivity to insulin. Journal of Hypertension 19: 113-118.

Repchinsky, C., R.D. Feldman, and J. Irvine. 2001. Adherance to Management of High Blood Pressure. Perspectives in Cardiology 17 (1): 14-20.
 
 

FINNIE, K.J.C.

Finnie, K.J., and L.J. Melendez. 2002. Choosing the correct rhythm strip. Canadian Journal of Diagnosis 19 (4): 67-68.

Finnie, K.J., and L.J. Melendez. 2002. The "Culprit" Vessel. Canadian Journal of Diagnosis 19 (5): 65-66.

Finnie, K.J., and L.J. Melendez. 2002. Pseudo-apoplectic attacks. Canadian Journal of Diagnosis 19 (3): 79-81.

Finnie, K.J., and L.J. Melendez. 2002. Tachycardia. 19 (6): 39-70.

Melendez, L.J., and K.J. Finnie. 2002. Hypotension and chest pain. Canadian Journal of Diagnosis 19 (1): 57-58.

Melendez, L.J., and K.J.C. Finnie. 2002. Bradycardia. Canadian Journal of Diagnosis 19 (2): 77-78.
 
 

FREEMAN, D.

Dresser, G., D. Baileym, B. Leakem, U. Schwartz, P. Dawson, D. Freeman, and R. Kim. 2002. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral bioavailability of fexofenadine. Clinical Pharmacology and Therapeutics 71 (1): 11-20.
 
 

GAWADRY-SRIDHAR, F.

Arnold, J.M.O., F. Gawadry-Sridhar, M. Calhoun, and S. Lawrence. 2001. Does intensive inpatient education of patients with heart failure (HF) during hospitalization result in fewer readmissions and visits to the emergency room (ER)? Canadian Journal of Cardiology 17 (Suppl C): 197C.
 
 

GEORGE, C.F.P.

George, C.F.P. 2001. Motor Vehicle Collisions are reduced when patients with sleep apnoea are treated with nasal CPAP. Thorax 56: 508-512.

George, C.F.P., L.J. Findley, M.A. Hack, and R.D. McEvoy. 2002. Across-Country Viewpoints on Sleepiness during Driving. American Journal of Respiratory and Critical Care Medicine 165: 746-749.
 
 

GILBERT, K.

Gilbert, K., and B.J. Larocque. 2002. Predicting Perioperative Cardiac Death in Non-cardiac Surgery. Journal of General Internal Medicine 17 (suppl): 112.

Lo, J.K., H.M. Finestone, K. Gilbert, and M.G. Woodbury. 2002. Community-Based Referrals for Electrodiagnostic Studies in Patients With Possible Carpal Tunnel Syndrome: What is the Diagnosis? Archives of Physical Medicine and Rehabilitation 83: 598-603.
 
 

GREGOR, J.C.

Gregor, J.C. 2001. Helicobacter pylori suppression: One more reason to consider selective gut decontamination. Journal of Critical Care 16 (4): 188.
 
 

GUENTHER, L.

Liu, K.E., B. Barankin, J. Howard, and L. Guenther. 2001. One-Year Followup on the Impact of a Sun Awareness Curriculum on Medical Students' Knowledge, Attitudes and Behaviour. Journal of Cutaneous Medicine and Surgery 5: 193-200.
 
 

HARTH, M.

Huisman, A.M., K.P. White, A. Algra, M. Harth, R. Vieth, J.W.G. Jacobs, J.W.J. Bijlsma, and D.A. Bell. 2001. Vitamin D metabolites in female systemic lupus erythematosus and fibromyalgia patients. Journal of Rheumatology 28: 2535-2539.

Rehman, F., M. Harth, and A.R. Spouge. 2002. Weber-Christian disease with severe polyarthritis and polyosteitis. Journal of Rheumatology 29: 1102-1103.

White, K.P., W.R. Nielson, M. Harth, T. Ostbye, and M. Speechley. 2002. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a represenetative community adult sample. Journal of Rheumatology 29: 588-594.
 
 

HEGELE, R.A.

Argmann, C.A., C.H. van Den Diepstraten, C.G. Sawyez, J.Y. Edwards, R.A. Hegele, B.M. Wolfe, and M.W. Huff. 2001. Transforming Growth Factor-B1 Inhibits Macrophage Cholesterol Ester Accumulation Induced by Native and Oxidized VLDL Remnants. Arteriosclerosis Thrombosis and Vascular Biology 21: 2011-2018.

Cao, H., and R.A. Hegele. 2001. Single nucleotide polymorphisms of the resistin (RSTN) gene. Journal of Human Genetics 46 (9): 553-555.

Cao, H., A. Mok, B. Miskie, and R.A. Hegele. 2001. Single-nucleotide polymorphisms of the proprotein convertase subtilisin/ kexin type 5 (PCSK5) gene. Journal of Human Genetics 46 (12): 730-732.

Cao, H., J. Yuen, and R. Hegele. 2001. Single nucleotide polymorphism of the fukutin gene. Journal of Human Genetics 46 (8): 487-489.

Hanley, A.J., G. McKeown-Eyssen, S.B. Harris, R.A. Hegele, T.M. Wolever, J. Kwan, P.W. Connelly, and B. Zinman. 2001. Cross sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid culture transition. Diabetes Care 24 (7): 1240-1247.

Hegele, R., S. Harris, B. Zinman, A. Hanley, and H. Cao. 2001. Absence of Association of Type 2 Diabetes with CAPN10 and PC-1 Polymorphisms in Oji-Cree. Diabetes Care 24 (8): 1498-1499.

Hegele, R.A. 2001. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism. American Journal of Human Genetics 69 (6): 1161-1177.

Hegele, R.A., M.R. Ban, C.V. Carrington, and D.D. Ramdath. 2001. Allele frequencies for candidate genes in atherosclerosis and diabetes among Trinidadian neonates. Human Biology 73: 525-531.

Hegele, R.A., M.R. Ban, and T.K. Young. 2001. Serum C-reactive protein in Canadian Inuit and its association with genetic variation on chromosome 1q21. Clinical Chemistry 47 (9): 1707-1709.

Hegele, R.A., D. Ramdath, M. Ban, M.N. Carruthers, Carrington C., and H. Cao. 2001. Polymorphisms in PNLIP, encoding pancreatic Lipase and associations with metabolic traits. Journal of Human Genetics 46 (6): 320-324.

Krahn, A.D., R. Yee, V. Chauhan, B. Spindler, A.C. Skanes, J. Wang, R. Hegele, B. Walker, and G.J. Klein. 2002. Beta blockers normalize QT hysteresis in long QT syndrome. American Heart Journal 143 (3): 528-534.

Near, S., J. Wang, and R. Hegele. 2001. Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene. Journal of Human Genetics 46 (8): 490-493.

Rocnik, E., R.A. Hegele, and J.G. Pickering. 2001. Hsp47 regulates collagen production by vascular smooth muscle cells: implications for plaque vulnerability. Circulation 104: II-66.

Rosset, J., J. Wang, B.M. Wolfe, P.J. Dolphin, and R.A. Hegele. 2001. Lecithin: cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity. Clinical Biochemistry 34 (5): 381-386.

Schaefer, E.J., M.E. Brousseau, M.R. Diffenderfer, J.S. Cohn, F.K. Welty, J. O'Connor, G.G. Dolnikowski, J. Wang, R.A. Hegele, and P.J. Jones. 2001. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 159: 231-236.

Wang, J., E. Huff, L. Janecka, and R.A. Hegele. 2001. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent. Human Mutation 18 (4): 359.

Wang, J., S. Near, K. Young, P.W. Connelly, and R.A. Hegele. 2001. ABCC6 gene polymorphism associated with variation in plasma lipoproteins. Journal of Human Genetics 46 (12): 699-705.
 
 

HODSMAN, A.B.

Hodsman, A.B. 2001. Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated. Peritoneal Dialysis International. 21. S247-S255.

Hodsman, A.B., D.A. Hanley, and R. Josse. 2002. Do bisphosphonates reduce the risk of osteoporotic fracture? An evaluation of the evidence to date. Canadian Medical Association Journal 166 (11): 1426-1430.
 
 

HOUSE, A.

Garg, A.X., W. Clark, R.B. Haynes, and A.A. House. 2002. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney International 61 (4): 1486-1494.
 
 

HOWARD, J.M.

Barankin, B., K. Liu, J. Howard, and L. Guenther. 2001. Effects of a Sun Protection Program Targeting Elementary School Children and Their Parents. Journal of Cutaneous Medicine and Surgery 5: 2-7.

Liu, K.E., B. Barankin, J. Howard, and L. Guenther. 2001. One-Year Followup on the Impact of a Sun Awareness Curriculum on Medical Students' Knowledge, Attitudes and Behaviour. Journal of Cutaneous Medicine and Surgery 5: 193-200.

Reniers, D.E., and J.M. Howard. 2001. Isotretinoin-induced Inflammatory Bowel Disease in an Adolescent. Annals of Pharmacotherapy 35: 1214-1216.
 
 

HOWSON-JAN, K.

Allan, D.S., M. Keeney, K. Howson-Jan, J. Popma, K. Weir, M. Bhatia, D.R. Sutherland, and I.H. Chin-Yee. 2002. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 29 (12): 967-972.

Murdoch, B., L. Gallacher, C. Awaraji, D.A. Hess, M. Keeney, K. Jay, K. Chadwick, S.R. Foley, K. Howson-Jan, I.H. Chin-Yee, D.M. Wu, E. Srour, F. Fellows, and M. Bhatia. 2001. Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. FASEB Journal 9 (July 15): 1628-1630.
 
 

HUFF, M.W.

Argmann, C.A., C.H. van Den Diepstraten, C.G. Sawyez, J.Y. Edwards, R.A. Hegele, B.M. Wolfe, and M.W. Huff. 2001. Transforming Growth Factor-B1 Inhibits Macrophage Cholesterol Ester Accumulation Induced by Native and Oxidized VLDL Remnants. Arteriosclerosis Thrombosis and Vascular Biology 21: 2011-2018.
 
 

HUMEN, D.

Haykowski, M., D. Taylor, K. Teo, A. Quinney, and D. Humen. 2001. Left ventricular wall stress during leg press exercise performed with a brief vascular maneuver. Chest 119 (1): 150-154.

Haykowsky, M., R. Welsh, D. Humen, D. Warburton, and D. Taylor. 2001. Impaired left ventricular systolic function after a half-ironman race. Canadian Journal of Cardiology 17 (6): 687-90.

King, K.M., D.P. Humen, H.L. Smith, C.L. Phan, and K.K. Teo. 2001. Predicting and explaining cardiac rehabilitation attendance. Canadian Journal of Cardiology 17 (3): 291-296.

King, K.M., D.P. Humen, H.L. Smith, C.L. Phan, and K.K. Teo. 2001. Psychosocial components of cardiac recovery and rehabilitation attendance. Heart 85 (3): 290-4.
 
 

HURWITZ, J.S.

Brymer, C., C. McKenzie, and J. Hurwitz. 2002. Use of the Levodopa test in the assessment of Parkinsonism on a geriatric inpatient unit. Geriatrics Today 5 (1): 22-28.

Wells, J.L., M.J. Borrie, C.D. Brymer, R.G. Crilly, and J.S. Hurwitz. 2002. A Novel Clinical Pharmacy Experience for Third Year Medical Students. Canadian Journal of Clinical Pharmacology 9: 7-16.
 
 

JEVNIKAR, A.M.

Chiu, P.P.L., A.M. Jevnikar, and J.S. Danska. 2001. Genetic control of T and B lymphocyte activation in nonobese diabetic mice. Journal of Immunology 167 (12): 7169-7179.

Ghanekar, A., Y. Luo, H. Yang, B. Garcia, P. Luke, S. Chakrabarti, G. Lajoie, MJ. Phillips, A. Katopodis, M.S. Cattral, W. Wall, A. Jevnikar, M. Bailey, G.A. Levy, D.R. Grant, and R. Zhong. 2001. The alpha-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts. Transplantation Proceedings 33 (7-8): 3853-3854.

Luke, P.P.W., C.A. O'Brien, A.M. Jevnikar, and R. Zhong. 2001. Anti CD45 RB monoclonal antibody-mediated transplantation tolerance. Current Molecular Medicine 1: 533-543.

Menassa, R., V. Nguyen, A.M. Jevnikar, and J. Brandle. 2001. A self-contained system for the field production of plant recombinant interleukin-10. Molecular Breeding 8 (2): 177-185.

Prange, S., P. Zucker, A.M. Jevnikar, and B. Singh. 2001. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients. Transplantation 71 (7): 982-985.
 
 

KHALIL, M.W.

Du, C., M.W. Khalil, and S. Sriram. 2001. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. Journal of Immunology 167: 7094-7101.

Du, C., G. Quinong, M.W. Khalil, and R. Sriram. 2001. Stimulation of Th2 response by high doses of dehydroepiandrosterone (DHEA). KLH primed splenocytes. Experimental Biology and Medicine 226: 1051-1060.

Ishida, Y., D.W. Killinger, K. Yang, B. Strutt, M.W. Khalil, and J.N.M. Heersche. 2002. Expression of steroid-converting enzymes in osteoblasts derived from rat vertebrae. Osteoporosis International 13 (3): 325-340.
 
 

KILLINGER, D.W.

Ishida, Y., D.W. Killinger, K. Yang, B. Strutt, M.W. Khalil, and J.N.M. Heersche. 2002. Expression of steroid-converting enzymes in osteoblasts derived from rat vertebrae. Osteoporosis International 13 (3): 325-340.
 
 

KLEIN, G.J.

DiMarco, J.P., G.J. Klein, and others. 2001. Cardiac Arrhythmias. Cardiology. M.H. Crawford, J.P. DiMarco, and G.J. Klein. London, UK: Harcourt Publishers. 1.1-10.18.

Gula, L.J., A.D. Krahn, R. Yee, A.C. Skanes, and G.J. Klein. 2002. A clinical approach to palpitations. Perspectives in Cardiology 18 (4): 26-36.

Humphries, K.H., C.R. Kerr, S.J. Connolly, G.J. Klein, J.A. Boone, M. Green, R. Sheldon, M. Talajic, P. Dorian, and D. Newman. 2001. New-onset atrial fibrillation: Sex differences in presentation, treatment, and outcome. ACP Journal Club 135: 112.

Krahn, A.D., G.J. Klein, A. Fitzpatrick, K.H. Seidl, A. Zaidi, A. Skanes, and R. Yee. 2002. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing and Clinical Electrophysiology 25: 37-41.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2002. Atrial fibrillation in Wolff Parkinson White Syndrome. Journal of Cardiovascular Electrophysiology 13 (3): 230.

Krahn, A.D., G.J. Klein, and R. Yee. 2001. A randomized, double-blind, placebo-controlled evaluatin of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome. Pacing and Cardiac Electrophysiology 24 (8): 1258-1260.

Krahn, A.D., G.J. Klein, R. Yee, and A. Skanes. 2002. Amiodarone: Pearl or peril? European Heart Journal 23 (3): 1001-1002.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Syncope. Cardiology. M.H. Crawford, and J.P. DiMarco. Mosby. 4.4.1-4.4.12.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The Use of implantable loop recorders in diagnosis of arrhythmias and syncope. Harrison's Text Book of Internal Medicine. McGraw-Hill. www.Harrisononline.com.

Krahn, A.D., L. Snell, R. Yee, J. Finan, A.C. Skanes, and G.J. Klein. 2002. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay. Canadian Journal of Cardiology 18 (4): 380-387.

Krahn, A.D., R. Yee, V. Chauhan, B. Spindler, A.C. Skanes, J. Wang, R. Hegele, B. Walker, and G.J. Klein. 2002. Beta blockers normalize QT hysteresis in long QT syndrome. American Heart Journal 143 (3): 528-534.

Le Lorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation? Clinical and Interventional Electrophysiology 3 (4): 301-304.

LeLorier, P., A.D. Krahn, G.J. Klein, R. Yee, and A. Skanes. 2002. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. American Journal of Cardiology 90 (1): 77-90.

Murgatroyd, F.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2002. Handbook of Cardiac Electrophysiology: A practical guide to invasive EP studies and catheter ablation. London, UK: ReMedica. 250 pp.

Seth, R., M.S. Green, C.R. Kerr, S.J. Connolly, G.J. Klein, R.S. Sheldon, M. Talajic, X. Wang, P. Dorian, and K. Humphries. 2002. Left atrial dimension is associated with atrial fibrillation recurrence: Four-year echo follow-up data. Journal of the American College of Cardiology 39 (5): 80A.

Sheldon, R., B.J. O'Brien, G. Blackhouse, R. Goeree, B. Mitchell, G.J. Klein, R.S. Roberts, M. Gent, and S.J. Connolly for the Canadian Implantable Defibrillator Study (CIDS) Investigators. 2001. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator. The Canadian Implantable Defibrillator Study. Circulation 104: 1622-1626.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, and R.S. Roberts Canadian Trial of Physiologic Pacing. 2001. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. Journal of the American College of Cardiology 38 (1): 167-172.
 
 

KORTAS, C.

Lindsay, R.M., R. Leitch, A.P. Heidenheim, and C. Kortas. 2001. Nocturnal hemodialysis [NH] but not short daily hemodialysis [SDH] requires an elevated dialysis calcium concentration. Journal of the American Society of Nephrology 12: 359.
 
 

KOVACS, M.J.

Allan, D.S., M.J. Kovacs, and W.F. Clark. 2001. Frequently Relapsing Thrombotic Thrombocytopenic Purpura Treated with Cytotoxic Immunosuppressive Therapy. Haematologica 8 (August): 844-850.

Boogaerts, M.A., A. Van Hoof, D. Catovsky, M. Kovacs, M. Montillo, P.L. Zinzani, J.L. Binet, W. Feremans, R. Marcus, F. Bosch, G. Verhoef, and M. Klein. 2001. Activity of Oral Fludarabine Phosphate in Previously Treated Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 19 (22): 4252-4258.

Quirt, B.I., C. Robeson, C.Y. Lau, M. Kovacs, S. Burdette-Radoux, S. Dolan, S.C. Tang, M. McKenzie, F. Couture, and Canadian Eprex Oncology Study Group. 2001. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. Journal of Clinical Oncology 21 (19): 4126-4134.

TAIST Investigators (Kovacs, M.J.). 2001. Tinzaparin in Acute Ischaemic Stroke (TAIST): A Randomised Aspirin-Controlled Trial. The Lancet 358 (September): 702-710.
 
 

KRAHN, A.D.

Gula, L.J., A.D. Krahn, R. Yee, A.C. Skanes, and G.J. Klein. 2002. A clinical approach to palpitations. Perspectives in Cardiology 18 (4): 26-36.

Krahn, A.D., G.J. Klein, A. Fitzpatrick, K.H. Seidl, A. Zaidi, A. Skanes, and R. Yee. 2002. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing and Clinical Electrophysiology 25: 37-41.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2002. Atrial fibrillation in Wolff Parkinson White Syndrome. Journal of Cardiovascular Electrophysiology 13 (3): 230.

Krahn, A.D., G.J. Klein, and R. Yee. 2001. A randomized, double-blind, placebo-controlled evaluatin of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome. Pacing and Cardiac Electrophysiology 24 (8): 1258-1260.

Krahn, A.D., G.J. Klein, R. Yee, and A. Skanes. 2002. Amiodarone: Pearl or peril? European Heart Journal 23 (3): 1001-1002.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Syncope. Cardiology. M.H. Crawford, and J.P. DiMarco. Mosby. 4.4.1-4.4.12.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The Use of implantable loop recorders in diagnosis of arrhythmias and syncope. Harrison's Text Book of Internal Medicine. McGraw-Hill. www.Harrisononline.com.

Krahn, A.D., L. Snell, R. Yee, J. Finan, A.C. Skanes, and G.J. Klein. 2002. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay. Canadian Journal of Cardiology 18 (4): 380-387.

Krahn, A.D., R. Yee, V. Chauhan, B. Spindler, A.C. Skanes, J. Wang, R. Hegele, B. Walker, and G.J. Klein. 2002. Beta blockers normalize QT hysteresis in long QT syndrome. American Heart Journal 143 (3): 528-534.

Le Lorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation? Clinical and Interventional Electrophysiology 3 (4): 301-304.

LeLorier, P., A.D. Krahn, G.J. Klein, R. Yee, and A. Skanes. 2002. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. American Journal of Cardiology 90 (1): 77-90.

Murgatroyd, F.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2002. Handbook of Cardiac Electrophysiology: A practical guide to invasive EP studies and catheter ablation. London, UK: ReMedica. 250 pp.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, and R.S. Roberts Canadian Trial of Physiologic Pacing. 2001. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. Journal of the American College of Cardiology 38 (1): 167-172.
 
 

LAROCQUE, B.J.

Gilbert, K., and B.J. Larocque. 2002. Predicting Perioperative Cardiac Death in Non-cardiac Surgery. Journal of General Internal Medicine 17 (suppl): 112.

The Propranolol Aneurysm Trial Investigators (Larocque, B.J., and J.L. Mahon). 2002. Propranolol for small abdominal aortic aneurisms: Results of a randomized trial. Journal of Vascular Surgery 35 (1): 72-79.
 
 

LEWIS, J.F.

Bosma, K.J., H.R. Campbell, L.A. McCaig, L.J. Yao, R.A. Veldhuizen, and J.F. Lewis. 2001. Polyethylene glycol inhibits exogenous surfactant in an in vivo acute lung injury model. American Journal of Respiratory and Critical Care Medicine 163 (55): A328.

Brackenbury, A., J.L. Malloy, L.A. McCaig, L.-J. Yao, R.A.W. Veldhuizen, and J.F. Lewis. 2002. Evaluation of alveolar surfactant aggregates in vitro and in vivo. European Respiratory Journal 19 (1): 41-46.

Campbell, H., K. Bosma, A. Brackenbury, L. McCaig, L.-J. Yao, R.A.W. Veldhuizen, and J. Lewis. 2002. Polyethylene Glycol (PEG) Mitigates the Efficacy of Exogenous Surfactant in Lung Injured Adult Rabbits. American Journal of Respiratory and Critical Care Medicine 165 (4): 475-480.

Lewis, J., and R. Veldhuizen. 2001. The role of the surfactant system in ventilation-induced lung injury. Recent Research Developments in Respiratory and Critical Care Medicine 1: 141-160.

Maitra, G., K. Inchley, R. Novick, R. Veldhuizen, J. Lewis, and F. Possmayer. 2002. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L67-74.

Malloy, J.L., R.A.W. Veldhuizen, F.X. McCormack, T.R. Korfhagen, J.A. Whitsett, and J.F. Lewis. 2002. Pulmonary Surfactant and Inflammation in Septic Adult Mice: Role of Surfactant Protein A. Journal of Applied Physiology 92 (2): 1169-1175.

Spragg, R., K. Harris, J. Lewis, J. March, W. Wurst, and F. Rathgeb. 2001. Surfactant treatment of patients in ARDS may reduce acute inflammation. American Journal of Respiratory and Critical Care Medicine 163 (55): A23.
 
 

LINDSAY, R.M.

Klarenbach, S., A.P. Heidenheim, R. Leitch, and R.M. Lindsay. 2002. Reduced requirements for erythropoeitin with quotidian hemodialysis therapy. ASAIO Journal 48 (1): 57-61.

Lindsay, R.M., M. Kiaii, S. Prakash, T. Shulamn, and A.P. Heidenheim. 2001. Extracellular fluid [ECF] and blood volume changes during hemodialysis [HD]. Journal of the American Society of Nephrology 12: 394.

Lindsay, R.M., R. Leitch, A.P. Heidenheim, and C. Kortas. 2001. Nocturnal hemodialysis [NH] but not short daily hemodialysis [SDH] requires an elevated dialysis calcium concentration. Journal of the American Society of Nephrology 12: 359.

Nesrallah, G., A. Bergman, A.P. Heidenheim, R. Leitch, and R.M. Lindsay. 2001. Short-hours daily and slow nocturnal hemodialysis improve blood pressure control: Are the mechanisms the same? Journal of the American Society of Nephrology 12: 273.

Prakash, S., A.P. Heidenheim, C. Kianfar, and R.M. Lindsay. 2001. Central and peripheral blood volume changes during hemodialysis. ASAIO Journal 47 (2): 153.

Shulman, T., A.P. Heidenheim, C. Kianfar, S.M. Shulman, and R.M. Lindsay. 2001. Preserving central blood volume: Changes in body fluid compartments during hemodialysis. ASAIO Journal 47 (6): 615-618.
 
 

MAHON, J.L.

Behme, M.T., J.L. Mahon, and J. Dupre. 2002. Autoantibodies and HLA susceptibility markers in Canadian first degree relatives of patients with type 1 diabetes. Annals of the New York Academy of Sciences 958: 228-231.

McDonald, J.W.D., J. Mahon, K. Zarnke, B. Feagan, L. Simms, and W. Tucker. 2002. A Randomized Survey of the Preference of Gastroenterolgists for a Cochrane Review versus a Traditional Narrative Review. Canadian Journal of Gastroenterology 16 (1): 17-21.

The Propranolol Aneurysm Trial Investigators (Larocque, B.J., and J.L. Mahon). 2002. Propranolol for small abdominal aortic aneurisms: Results of a randomized trial. Journal of Vascular Surgery 35 (1): 72-79.
 
 

MASSEL, D.R.

Al-Ghamdi, A., D. Massel, and L. Melendez. 2001. Ejection fraction velocity ratio (EFVR) as a simple echocardiographic indicator of severity of aortic stenosis. Canadian Journal of Cardiology 17 (Suppl C): 268 C.

Gula, L.J., and D. Massel. 2002. Combining electrocardiography and necrosis biomarkers improved detection of acute myocardial infarction in patients with LBBB. Annals of Internal Medicine (ACP Journal Club) 136 (suppl 1): 29.

Huyhn, T., D. Massel, K. Webster, J. Hilbe, and P. Daly for the FASTRAK Investigators. 2001. Predictors for increased risk of hemorrhagic stroke among thrombolyzed patients enrolled in the FASTRAK II Registry. Canadian Journal of Cardiology 17 (suppl C): 208.

Kiaii, B., B.C. Moon, D. Massel, Y. Langlois, T.W. Austin, A. Willoughby, C. Guiraudon, C.R. Howard, and L.R. Guo. 2002. A prospective randomized trial of endoscopic versus conventional harvesting of the saphenous vein. Journal of Thoracic and Cardiovascular Surgery 123: 204-12.

Massel, D. 2001. Enoxaparin in acute coronary syndromes: A meta-analysis showing superiority versus placebo. Canadian Journal of Cardiology 17 (suppl c): 165 C.

Massel, D., and M.K. Cruickshank. 2002. The number remaining at risk. An adjunct to the number needed to treat. Canadian Journal of Cardiology 18: 254-258.

Prabhakar, M., and D. Massel. 2002. Review: Some new bolus tPA-derived fibrinolytics are comparable to tPA in acute MI, but other increase bleeding. Annals of Internal Medicine 136 (suppl 1): 6.

Vlasic, W., D. Almond, and D. Massel. 2001. Reducing bedrest following arterial puncture for coronary interventional Procedures - Impact on Vascular Complications: The BAC Trial. Journal of Invasive Cardiology 13 (12): 788-792.
 
 

MAZZA, J.

Mazza, J., D. Moote, K. Payton, and F. Mazza. 2002. Compliance with the Canadian Asthma Guidelines in different medical practices. Canadian Journal of Allergy and Clinical Immunology 7 (3/4): 47.
 
 

MCCORMACK, D.G.

Hirani, N., K. Kemp, S. Weicker, D. McCormack, and S. Mehta. 2002. A randomized, placebo-controlled trial of inhaled nitric oxide as an adjunctive therapy for patients hospitalized with community-acquired pneumonia (CAP). American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A780.

Jankowicz, A., A. Yaghi, S. Weicker, S. Mehta, and D.G. McCormack. 2002. The role of heme oxygenase in modulation of the expression and activity of nitric oxide synthase in sepsis-induced lung injury. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A477.

Razavi, H., R. Werhun, J.A. Scott, S. Weicker, L.F. Wang, D.G. McCormack, and S. Mehta. 2002. Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Critical Care Medicine 30: 868-873.

Razavi, H.M., L.F. Wang, S. Weicker, D.G. McCormack, and S. Mehta. 2002. Macrophage dependent neutrophil recruitment in sepsis induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A477.

Razavi, H.M., R. Werhun, J.A. Scott, S. Weicker, L.F. Wang, D.G. McCormack, and S. Mehta. 2002. Effects of inhaled nitric oxide in a mouse model of sepsis-induced lung injury. Critical Care Medicine 30 (4): 868-873.

Wang, L.F., S. Weicker, S. Mehta, G. Cepinskas, P. Kvietys, and D.G. McCormack. 2002. Inducible Nitric Oxide Synthase (iNOS) in Mouse Pulmonary Microvascular Endothelial Cells (EC) Does Not Contribute to In Vitro Hyperpermeability Induced by Lipopolysaccharide and Vascular EC Growth Factor. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A753.
 
 

MCDONALD, J.W.D.

McDonald, J.W.D., J. Mahon, K. Zarnke, B. Feagan, L. Simms, and W. Tucker. 2002. A Randomized Survey of the Preference of Gastroenterolgists for a Cochrane Review versus a Traditional Narrative Review. Canadian Journal of Gastroenterology 16 (1): 17-21.
 
 

MEHTA, S.

Carpenter, S., C. Bayliff, and S. Mehta. 2002. Fluoroquinolone-induced acute interstitial nephritis. Canadian Journal of Hospital Pharmacy 55: 139-142.

Hirani, N., K. Kemp, S. Weicker, D. McCormack, and S. Mehta. 2002. A randomized, placebo-controlled trial of inhaled nitric oxide as an adjunctive therapy for patients hospitalized with community-acquired pneumonia (CAP). American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A780.

Jankowicz, A., A. Yaghi, S. Weicker, S. Mehta, and D.G. McCormack. 2002. The role of heme oxygenase in modulation of the expression and activity of nitric oxide synthase in sepsis-induced lung injury. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A477.

Razavi, H., R. Werhun, J.A. Scott, S. Weicker, L.F. Wang, D.G. McCormack, and S. Mehta. 2002. Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Critical Care Medicine 30: 868-873.

Razavi, H.M., L.F. Wang, S. Weicker, D.G. McCormack, and S. Mehta. 2002. Macrophage dependent neutrophil recruitment in sepsis induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A477.

Razavi, H.M., R. Werhun, J.A. Scott, S. Weicker, L.F. Wang, D.G. McCormack, and S. Mehta. 2002. Effects of inhaled nitric oxide in a mouse model of sepsis-induced lung injury. Critical Care Medicine 30 (4): 868-873.

Wang, L.F., S. Weicker, S. Mehta, G. Cepinskas, P. Kvietys, and D.G. McCormack. 2002. Inducible Nitric Oxide Synthase (iNOS) in Mouse Pulmonary Microvascular Endothelial Cells (EC) Does Not Contribute to In Vitro Hyperpermeability Induced by Lipopolysaccharide and Vascular EC Growth Factor. American Journal of Respiratory and Critical Care Medicine 165 (8, pt 2): A753.
 
 

MELENDEZ, L.J.

Al-Ghamdi, A., D. Massel, and L. Melendez. 2001. Ejection fraction velocity ratio (EFVR) as a simple echocardiographic indicator of severity of aortic stenosis. Canadian Journal of Cardiology 17 (Suppl C): 268 C.

Finnie, K.J., and L.J. Melendez. 2002. Choosing the correct rhythm strip. Canadian Journal of Diagnosis 19 (4): 67-68.

Finnie, K.J., and L.J. Melendez. 2002. The "Culprit" Vessel. Canadian Journal of Diagnosis 19 (5): 65-66.

Finnie, K.J., and L.J. Melendez. 2002. Pseudo-apoplectic attacks. Canadian Journal of Diagnosis 19 (3): 79-81.

Finnie, K.J., and L.J. Melendez. 2002. Tachycardia. 19 (6): 39-70.

Melendez, L.J., and K.J. Finnie. 2002. Hypotension and chest pain. Canadian Journal of Diagnosis 19 (1): 57-58.

Melendez, L.J., and K.J.C. Finnie. 2002. Bradycardia. Canadian Journal of Diagnosis 19 (2): 77-78.
 
 

MOOTE, D.W.

Lacuesta, G., D.W. Moote, K. Payton, and J. Mazza. 2002. Follow-up of patients with negative skin tests to penicillin. Canadian Journal of Allergy and Clinical Immunology 7 (3/4): 45.

Mazza, J., D. Moote, K. Payton, and F. Mazza. 2002. Compliance with the Canadian Asthma Guidelines in different medical practices. Canadian Journal of Allergy and Clinical Immunology 7 (3/4): 47.
 
 

MUIRHEAD, N.

MacDonald, A.S. for The Rapammune Global Study Group (Muirhead, N.). 2001. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 71 (2): 271-280.

Muirhead, N. 2001. The rationale for early management of chronic renal insufficiency. Nephrology Dialysis Transplantation 16 (Suppl 7): 51-56.

Tonelli, M., P.G. Blake, and N. Muirhead. 2001. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. ASAIO Journal 47 (1): 82-85.

Valderrabano, F., T. Golper, N. Muirhead, E. Ritz, and A. Levin. 2001. Chronic kidney disease: why is current management uncoordinated and suboptimal? Nephrology Dialysis Transplantation 16 (Suppl 7): 61-64.
 
 

NIELSON, W.R.

White, K.P., W.R. Nielson, M. Harth, T. Ostbye, and M. Speechley. 2002. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a represenetative community adult sample. Journal of Rheumatology 29: 588-594.
 
 

PATERSON, N.A.M.

Endicott, T.J., B.J. Fisher, E. Wong, N.A.M. Paterson, L.E. Gaspar, and M. Bauman. 2001. Pulmonary sequelae after electron spinal irradiation. Radiotherapy and Oncology 60 (3): 267-272.

Price, D.B., M.Y. Rouleau, C.P. Fletcher, P. Patel, Olivenstein R., L. Lyhr, J.C. Virchow, W.R.C. Aichison, E.R. Omenaas, P.S. Dellea, M. Laurenzi, J.A. Lef, and N.A.M. Paterson (with Montelukast/inhaled steroid taper study group). 2001. Use of Montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial. Current Therapeutic Research 62 (11): 743-755.
 
 

PAYTON, K.B.

Lacuesta, G., D.W. Moote, K. Payton, and J. Mazza. 2002. Follow-up of patients with negative skin tests to penicillin. Canadian Journal of Allergy and Clinical Immunology 7 (3/4): 45.

Mazza, J., D. Moote, K. Payton, and F. Mazza. 2002. Compliance with the Canadian Asthma Guidelines in different medical practices. Canadian Journal of Allergy and Clinical Immunology 7 (3/4): 47.
 
 

PFLUGFELDER, P.

Liu, P., J.M.O. Arnold, M.I. Belenkie, J. Howlett, V. Huckell, A. Ignazewski, M.-H. LeBlanc, R. McKelvie, J. Niznick, J.D. Parker, V. Rao, H. Ross, D. Roy, S. Smith, B. Sussex, K. Teo, R. Tsuyuki, M. White, D. Beanlands, V. Bernstein, R. Davies, D. Issac, D. Johnstone, H. Lee, G. Moe, G. Newton, P. Pflugfelder, S. Roth, J. Rouleau, and S. Yusuf. 2001. The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure. Canadian Journal of Cardiology 17 (Suppl E): 5E-25E.
 
 

PICKERING, J.G.

Fera, E.V., C. Van Den Diepstraten, B. Carruthers, and J.G. Pickering. 2001. FGF-2 stimulates lamellipodial activity of smooth muscle cells on collagen by indirect activation of Rac1. Circulation 104: II258.

Li, S., Y.-S. Fan, L.H. Chow, C. Van Den Diepstraten, E. van der Veer, S.M. Sims, and J.G. Pickering. 2001. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circulation Research 89: 517-525.

Rocnik, E., R.A. Hegele, and J.G. Pickering. 2001. Hsp47 regulates collagen production by vascular smooth muscle cells: implications for plaque vulnerability. Circulation 104: II-66.

Van Den Diepstraten, C., K. Papay, Z. Pravda, and J.G. Pickering. 2001. Cloning of a novel prolyl hydroxylase-like gene from human smooth muscle cells. Canadian Journal of Cardiology 17 (Suppl C): 162C.
 
 

POPE, J.E.

Alrehaily, A., and J.E. Pope. 2002. Alkaptonuria With Atypical Joint Involvement. Journal of Rheumatology (Images in Rheumatology) 29 (1): 198-199.

Pope, J.E., N. Bellamy, and J.R. Seibold. 2001. A Randomized Controlled Trial Of Methotrexate Versus Placebo In Early Diffuse Scleroderma. Arthritis and Rheumatism 44: 1351-1358.

Pope, J.E., P. Hong, and B.E. Koehler. 2002. DMARDs Prescribing Trends In Rheumatoid Arthritis: A Survey Of Practicing Canadian Rheumatologists. Journal of Rheumatology 29: 255-260.

Thompson, A.E., B. Shea, V. Welch, D. Fenlon, and J. Pope. 2001. Calcium channel blockers for Raynaud's phenomenon in progressive systemic sclerosis. Arthritis and Rheumatism 44 (8): 1841-1847.
 
 

PROKOPIW, I.

Puligandia, P.S., L. Becker, D. Driman, I. Prokopiw, D. Taves, and Davies E.T. 2001. Inverted Meckel's diverticulum presenting as chronic anemia: case report and review of the literature. Canadian Journal Of Surgery 44: 458-459.
 
 

SKANES, A.C.

Gula, L.J., A.D. Krahn, R. Yee, A.C. Skanes, and G.J. Klein. 2002. A clinical approach to palpitations. Perspectives in Cardiology 18 (4): 26-36.

Krahn, A.D., G.J. Klein, A. Fitzpatrick, K.H. Seidl, A. Zaidi, A. Skanes, and R. Yee. 2002. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing and Clinical Electrophysiology 25: 37-41.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2002. Atrial fibrillation in Wolff Parkinson White Syndrome. Journal of Cardiovascular Electrophysiology 13 (3): 230.

Krahn, A.D., G.J. Klein, R. Yee, and A. Skanes. 2002. Amiodarone: Pearl or peril? European Heart Journal 23 (3): 1001-1002.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Syncope. Cardiology. M.H. Crawford, and J.P. DiMarco. Mosby. 4.4.1-4.4.12.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The Use of implantable loop recorders in diagnosis of arrhythmias and syncope. Harrison's Text Book of Internal Medicine. McGraw-Hill. www.Harrisononline.com.

Krahn, A.D., L. Snell, R. Yee, J. Finan, A.C. Skanes, and G.J. Klein. 2002. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay. Canadian Journal of Cardiology 18 (4): 380-387.

Krahn, A.D., R. Yee, V. Chauhan, B. Spindler, A.C. Skanes, J. Wang, R. Hegele, B. Walker, and G.J. Klein. 2002. Beta blockers normalize QT hysteresis in long QT syndrome. American Heart Journal 143 (3): 528-534.

Le Lorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation? Clinical and Interventional Electrophysiology 3 (4): 301-304.

LeLorier, P., A.D. Krahn, G.J. Klein, R. Yee, and A. Skanes. 2002. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. American Journal of Cardiology 90 (1): 77-90.

Murgatroyd, F.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2002. Handbook of Cardiac Electrophysiology: A practical guide to invasive EP studies and catheter ablation. London, UK: ReMedica. 250 pp.

Skanes, A.C. 2001. Clinical approach to an abnormal ECG. Electrophysiological Disorders of the heart. San Francisco: Harcourt.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, and R.S. Roberts Canadian Trial of Physiologic Pacing. 2001. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. Journal of the American College of Cardiology 38 (1): 167-172.
 
 

THOMPSON, M.J.

White, K.P., and M.J. Thompson. 2001. The prevalence of chronic widespread pain (CWP) in a rural community in Southwestern Ontario. Arthritis and Rheumatism 44 (S9): S230 #1063.

White, K.P., and M.J. Thompson. 2001. The prevalence of frequent and debilitating fatigue in a rural community in Southwestern Ontario. Arthritis and Rheumatism 44 (S9): S230 #1064.
 
 

VELDHUIZEN, R.A.W.

Bosma, K.J., H.R. Campbell, L.A. McCaig, L.J. Yao, R.A. Veldhuizen, and J.F. Lewis. 2001. Polyethylene glycol inhibits exogenous surfactant in an in vivo acute lung injury model. American Journal of Respiratory and Critical Care Medicine 163 (55): A328.

Brackenbury, A., J.L. Malloy, L.A. McCaig, L.-J. Yao, R.A.W. Veldhuizen, and J.F. Lewis. 2002. Evaluation of alveolar surfactant aggregates in vitro and in vivo. European Respiratory Journal 19 (1): 41-46.

Campbell, H., K. Bosma, A. Brackenbury, L. McCaig, L.-J. Yao, R.A.W. Veldhuizen, and J. Lewis. 2002. Polyethylene Glycol (PEG) Mitigates the Efficacy of Exogenous Surfactant in Lung Injured Adult Rabbits. American Journal of Respiratory and Critical Care Medicine 165 (4): 475-480.

Lewis, J., and R. Veldhuizen. 2001. The role of the surfactant system in ventilation-induced lung injury. Recent Research Developments in Respiratory and Critical Care Medicine 1: 141-160.

Maitra, G., K. Inchley, R. Novick, R. Veldhuizen, J. Lewis, and F. Possmayer. 2002. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L67-74.

Malloy, J.L., R.A.W. Veldhuizen, F.X. McCormack, T.R. Korfhagen, J.A. Whitsett, and J.F. Lewis. 2002. Pulmonary Surfactant and Inflammation in Septic Adult Mice: Role of Surfactant Protein A. Journal of Applied Physiology 92 (2): 1169-1175.

Veldhuizen, R.A.W., A.S. Slutsky, M. Joseph, and L.A.M. McCaig. 2001. Effects of mechanical ventilation of isolated mouse lungs on pulmonary surfactant and inflammatory cytokines. The European Respiratory Journal 17: 488-494.

Veldhuizen, R.A.W., B. Welk, R. Harbottle, S. Hearn, K. Nag, N. Petersen, and F. Possmayer. 2002. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. Journal of Applied Physiology 92 (3): 1169-1175.

Welk, B., J.L. Malloy, M. Joseph, L.-J. Yao, and R.A.W. Veldhuizen. 2001. Surfactant treatment for ventilation induced lung injury in rats; effects on lung compliance and cytokines. Experimental Lung Research 27 (6): 505-520.
 
 

WELLS, J.L.

Borrie, M.J., P. Stolee, J.L. Wells, J. Seabrook, and F. Knoefel. 2001. Current Best Practices in Geriatric Rehabilitation in Canada. Geriatrics Today: Journal of the Canadian Geriatric Society 4 (3): 118.

Diachun, L.D., J.L. Wells, J. Esbaugh, and C.D. Brymer. 2001. The Efficacy of Experential Learning of Geriatric Curriculum in First Year Medical Students at UWO. Geriatrics Today 4 (3): 117-118.

Knoefel, F., B. Helliwell, M.J. Borrie, P. Stolee, and J. Wells. 2001. A Comparison of Functional Independence and Medical Complexity in Geriatric and Physical Medicine Rehabiliation In-patients. Geriatrics Today: Journal of the Canadian Geriatric Society 4 (3): 120-121.

Wells, J.L., M.J. Borrie, C.D. Brymer, R.G. Crilly, and J.S. Hurwitz. 2002. A Novel Clinical Pharmacy Experience for Third Year Medical Students. Canadian Journal of Clinical Pharmacology 9: 7-16.

Wells, J.L., M.J. Borrie, F. Knoefel, and P. Stolee. 2001. Geriatric Rehabilitation: Best Practices and Best Outcomes. Gerontology 47 (Suppl 1): 679.
 
 

WHITE, K.P.

Huisman, A.M., K.P. White, A. Algra, M. Harth, R. Vieth, J.W.G. Jacobs, J.W.J. Bijlsma, and D.A. Bell. 2001. Vitamin D metabolites in female systemic lupus erythematosus and fibromyalgia patients. Journal of Rheumatology 28: 2535-2539.

White, K.P., W.R. Nielson, M. Harth, T. Ostbye, and M. Speechley. 2002. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a represenetative community adult sample. Journal of Rheumatology 29: 588-594.

White, K.P., and M.J. Thompson. 2001. The prevalence of chronic widespread pain (CWP) in a rural community in Southwestern Ontario. Arthritis and Rheumatism 44 (S9): S230 #1063.

White, K.P., and M.J. Thompson. 2001. The prevalence of frequent and debilitating fatigue in a rural community in Southwestern Ontario. Arthritis and Rheumatism 44 (S9): S230 #1064.
 
 

WISENBERG, G.

Bellamy, D.D., R.S. Pereira, C.A. McKenzie, F.S. Prato, D.J. Drost, J. Sykes, and G. Wisenberg. 2002. Gd-DTPA bolus tracking in the myocardium using T1 fast acquisition relaxation mapping (Ti FARM). Magnetic Resonance in Medicine 46 (3): 555-564.

Pereira, R.S., F.S. Prato, G. Wisenberg, J. Sykes, and K.J. Yvorchuk. 2001. The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. International Journal of Cardiac Imaging 17 (5): 395-404.

Thornhill, R.E., F.S. Prato, R.S. Pereira, G. Wisenberg, and J. Sykes. 2001. Examining a canine model of stunned myocardium with DTPA-enhanced MRI. Magnetic Resonance in Medicine 45: 864-871.
 
 

WOLFE, B.M.

Argmann, C.A., C.H. van Den Diepstraten, C.G. Sawyez, J.Y. Edwards, R.A. Hegele, B.M. Wolfe, and M.W. Huff. 2001. Transforming Growth Factor-B1 Inhibits Macrophage Cholesterol Ester Accumulation Induced by Native and Oxidized VLDL Remnants. Arteriosclerosis Thrombosis and Vascular Biology 21: 2011-2018.

Rosset, J., J. Wang, B.M. Wolfe, P.J. Dolphin, and R.A. Hegele. 2001. Lecithin: cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity. Clinical Biochemistry 34 (5): 381-386.
 
 

YEE, R.

Gula, L.J., A.D. Krahn, R. Yee, A.C. Skanes, and G.J. Klein. 2002. A clinical approach to palpitations. Perspectives in Cardiology 18 (4): 26-36.

Krahn, A.D., G.J. Klein, A. Fitzpatrick, K.H. Seidl, A. Zaidi, A. Skanes, and R. Yee. 2002. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing and Clinical Electrophysiology 25: 37-41.

Krahn, A.D., G.J. Klein, A.C. Skanes, and R. Yee. 2002. Atrial fibrillation in Wolff Parkinson White Syndrome. Journal of Cardiovascular Electrophysiology 13 (3): 230.

Krahn, A.D., G.J. Klein, and R. Yee. 2001. A randomized, double-blind, placebo-controlled evaluatin of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome. Pacing and Cardiac Electrophysiology 24 (8): 1258-1260.

Krahn, A.D., G.J. Klein, R. Yee, and A. Skanes. 2002. Amiodarone: Pearl or peril? European Heart Journal 23 (3): 1001-1002.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. Syncope. Cardiology. M.H. Crawford, and J.P. DiMarco. Mosby. 4.4.1-4.4.12.

Krahn, A.D., G.J. Klein, R. Yee, and A.C. Skanes. 2001. The Use of implantable loop recorders in diagnosis of arrhythmias and syncope. Harrison's Text Book of Internal Medicine. McGraw-Hill. www.Harrisononline.com.

Krahn, A.D., L. Snell, R. Yee, J. Finan, A.C. Skanes, and G.J. Klein. 2002. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay. Canadian Journal of Cardiology 18 (4): 380-387.

Krahn, A.D., R. Yee, V. Chauhan, B. Spindler, A.C. Skanes, J. Wang, R. Hegele, B. Walker, and G.J. Klein. 2002. Beta blockers normalize QT hysteresis in long QT syndrome. American Heart Journal 143 (3): 528-534.

Lau, C., S.C. Nishimura, R. Yee, C. LeFeuvre, F. Philippon, and D.A. Cameron. 2001. Intraoperative study of polarization and evoked response signals in different endocardial electrode desings. Pacing and Cardiac Electrophysiology 24: 1055-1060.

Le Lorier, P., G.J. Klein, A. Krahn, R. Yee, and A. Skanes. 2001. Should patients with asymptomatic Wolff-Parkinson-White pattern undergo a catheter ablation? Clinical and Interventional Electrophysiology 3 (4): 301-304.

LeLorier, P., A.D. Krahn, G.J. Klein, R. Yee, and A. Skanes. 2002. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. American Journal of Cardiology 90 (1): 77-90.

Murgatroyd, F.D., A.D. Krahn, G.J. Klein, R. Yee, and A.C. Skanes. 2002. Handbook of Cardiac Electrophysiology: A practical guide to invasive EP studies and catheter ablation. London, UK: ReMedica. 250 pp.

Skanes, A.C., A.D. Krahn, R. Yee, G.J. Klein, S.J. Connolly, C.R. Kerr, M. Gent, K.E. Thorpe, and R.S. Roberts Canadian Trial of Physiologic Pacing. 2001. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. Journal of the American College of Cardiology 38 (1): 167-172.
 
 

YVORCHUK, K.J.

Pereira, R.S., F.S. Prato, G. Wisenberg, J. Sykes, and K.J. Yvorchuk. 2001. The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. International Journal of Cardiac Imaging 17 (5): 395-404.
 
 

ZARNKE, K.B.

The Canadian Hypertension Recommendations Working Group (Zarnke, K.B.). 2001. The 2000 Canadian Hypertension Recommendations: A Summary. Canadian Journal of Cardiology 17 (5): 535-538.

The Canadian Hypertension Recommendations Working Group (Zarnke, K.B.). 2002. The 2001 Canadian Hypertension Recommendations. Perspectives in Cardiology 18 (2): 38-46.

McDonald, J.W.D., J. Mahon, K. Zarnke, B. Feagan, L. Simms, and W. Tucker. 2002. A Randomized Survey of the Preference of Gastroenterolgists for a Cochrane Review versus a Traditional Narrative Review. Canadian Journal of Gastroenterology 16 (1): 17-21.

Zarnke, K.B., M. Levine, F.A. McAlister, N.R.C. Campbell, M.G. Myers, D. McKay, P. Bolli, G. Honos, M. Lebel, K. Mann, T.W. Wilson, C. Abbott, S. Tobe, E. Burgess, and S. Rabkin for the Canadian HTN Recommendations Working Group. 2001. The 2000 Canadian recommendations for the management of hypertension: Part two - diagnosis and assessment of persons with high blood pressure. Canadian Journal of Cardiology 17 (12): 1249-1263.